Daily Symptom Home Monitoring Decreases Hospital Readmissions in Children and Young Adults With Acute Lymphoblastic

Rotem Fishel Ben-Kenan1, Laura L Retson1,2, Briana Fodor3

  • 1Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.

Cancer Medicine
|April 9, 2026
PubMed

Insights

Daily symptom monitoring via text messages for pediatric Acute Lymphoblastic Leukemia patients significantly reduced hospital readmissions. This intervention allowed for timely nursing care, improving patient outcomes without increasing caregiver distress.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Digital Health

Background:

  • Acute Lymphoblastic Leukemia (ALL) treatments improve survival but cause significant morbidity.
  • Effective management of treatment-related complications is crucial for pediatric ALL patients.

Purpose of the Study:

  • To evaluate if daily symptom home monitoring with targeted nursing intervention reduces readmission rates in newly diagnosed pediatric and adolescent young adults with ALL.

Main Methods:

  • A daily symptom survey was texted to participants undergoing initial ALL chemotherapy.
  • Nurse clinicians monitored responses and intervened as needed.
  • Readmission rates and days at home were compared to a control group.

Main Results:

  • The intervention group had significantly lower readmission rates (82.8% vs 55.6%, p=0.028).
  • Patients in the intervention group spent more days at home (18.7 vs 16.4 days).
  • No significant differences in demographics or caregiver distress were observed.

Conclusions:

  • Daily symptom home monitoring and targeted nursing intervention effectively decreased ALL patient readmissions.
  • This approach facilitates timely interventions for patient morbidities.
  • The strategy improved patient outcomes without increasing caregiver distress.
Abstract